Published in Proteome Sci on April 17, 2009
Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J Transl Med (2011) 1.36
Human cervicovaginal mucus contains an activity that hinders HIV-1 movement. Mucosal Immunol (2012) 1.35
Proteome, phosphoproteome, and hydroxyproteome of liver mitochondria in diabetic rats at early pathogenic stages. Mol Cell Proteomics (2009) 1.27
Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts. Future Microbiol (2011) 1.25
Release of luminal exosomes contributes to TLR4-mediated epithelial antimicrobial defense. PLoS Pathog (2013) 1.01
Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract. Proteome Sci (2010) 0.96
Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model. Biol Reprod (2012) 0.86
Amniotic fluid cathelicidin in PPROM pregnancies: from proteomic discovery to assessing its potential in inflammatory complications diagnosis. PLoS One (2012) 0.86
Cervicovaginal microbiome dysbiosis is associated with proteome changes related to alterations of the cervicovaginal mucosal barrier. Mucosal Immunol (2015) 0.85
Studying the effects of reproductive hormones and bacterial vaginosis on the glycome of lavage samples from the cervicovaginal cavity. PLoS One (2015) 0.82
Anti-HIV activity of human defensin 5 in primary CD4+ T cells under serum-deprived conditions is a consequence of defensin-mediated cytotoxicity. PLoS One (2013) 0.82
Discrimination of grade 2 and 3 cervical intraepithelial neoplasia by means of analysis of water soluble proteins recovered from cervical biopsies. Proteome Sci (2011) 0.82
Identification of protein biomarkers for cervical cancer using human cervicovaginal fluid. PLoS One (2014) 0.82
Body fluid identification by mass spectrometry. Int J Legal Med (2013) 0.82
Proteomes of the Female Genital Tract During the Oestrous Cycle. Mol Cell Proteomics (2015) 0.81
Human cervicovaginal fluid biomarkers to predict term and preterm labor. Front Physiol (2015) 0.81
Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus. Mucosal Immunol (2015) 0.81
Is vitamin D binding protein a novel predictor of labour? PLoS One (2013) 0.80
Proteomic analysis of menstrual blood. Mol Cell Proteomics (2012) 0.78
HIV-Enhancing Factors Are Secreted by Reproductive Epithelia upon Inoculation with Bacterial Vaginosis-Associated Bacteria. Protein Pept Lett (2015) 0.77
Prediction of spontaneous regression of cervical intraepithelial neoplasia lesions grades 2 and 3 by proteomic analysis. Int J Proteomics (2014) 0.77
Predicting Preterm Labour: Current Status and Future Prospects. Dis Markers (2015) 0.76
Kinin release from human kininogen by 10 aspartic proteases produced by pathogenic yeast Candida albicans. BMC Microbiol (2015) 0.76
IPA Analysis of Cervicovaginal Fluid from Precancerous Women Points to the Presence of Biomarkers for the Precancerous State of Cervical Carcinoma. Proteomes (2014) 0.75
A feasibility study to identify proteins in the residual Pap test fluid of women with normal cytology by mass spectrometry-based proteomics. Clin Proteomics (2014) 0.75
Putative functions of tissue kallikrein-related peptidases in vaginal fluid. Nat Rev Urol (2016) 0.75
Unique Insights in the Cervicovaginal Lactobacillus iners and L. crispatus Proteomes and Their Associations with Microbiota Dysbiosis. PLoS One (2016) 0.75
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol (2003) 84.79
Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods (2007) 25.29
Neutrophil extracellular traps kill bacteria. Science (2004) 23.64
PANTHER: a library of protein families and subfamilies indexed by function. Genome Res (2003) 21.64
A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem (2004) 19.20
Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics (2005) 10.67
Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics (2005) 8.14
An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem (2001) 6.90
PANTHER version 6: protein sequence and function evolution data with expanded representation of biological pathways. Nucleic Acids Res (2006) 6.20
DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol (2006) 5.22
Interaction of human defensins with Escherichia coli. Mechanism of bactericidal activity. J Clin Invest (1989) 5.21
Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol (2006) 4.47
Correlation of relative abundance ratios derived from peptide ion chromatograms and spectrum counting for quantitative proteomic analysis using stable isotope labeling. Anal Chem (2005) 4.16
An improved model for prediction of retention times of tryptic peptides in ion pair reversed-phase HPLC: its application to protein peptide mapping by off-line HPLC-MALDI MS. Mol Cell Proteomics (2004) 3.74
Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics (2002) 3.57
The proteome of the mouse photoreceptor sensory cilium complex. Mol Cell Proteomics (2007) 3.53
Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics (2003) 3.34
Intestinal epithelial cells secrete exosome-like vesicles. Gastroenterology (2001) 3.33
Cationic host defense (antimicrobial) peptides. Curr Opin Immunol (2005) 2.71
Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis (2000) 2.64
Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. AIDS (2003) 2.55
Bricks and mortar of the epidermal barrier. Exp Mol Med (1999) 2.37
The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun (1999) 2.35
Induction of heat shock proteins in B-cell exosomes. J Cell Sci (2005) 2.21
Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr (2003) 2.16
Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics (2006) 2.14
Calprotectin - a pleiotropic molecule in acute and chronic inflammation. Physiol Res (2004) 1.88
Cationic polypeptides are required for anti-HIV-1 activity of human vaginal fluid. J Immunol (2005) 1.82
The innate and early immune response to pathogen challenge in the female genital tract and the pivotal role of epithelial cells. J Reprod Immunol (2002) 1.81
Antimicrobial components of vaginal fluid. Am J Obstet Gynecol (2002) 1.67
Identification of novel protein biomarkers of preterm birth in human cervical-vaginal fluid. J Proteome Res (2007) 1.58
Biomarkers: mining the biofluid proteome. Mol Cell Proteomics (2005) 1.55
Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem (2006) 1.54
Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future. J Proteome Res (2007) 1.52
Antiviral activities of lactoferrin. Antiviral Res (2001) 1.49
Innate host defense of human vaginal and cervical mucosae. Curr Top Microbiol Immunol (2006) 1.48
Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J Clin Invest (2005) 1.47
Comprehensive proteomic analysis of human cervical-vaginal fluid. J Proteome Res (2007) 1.46
Quantitative shotgun proteomics using a protease with broad specificity and normalized spectral abundance factors. Mol Biosyst (2007) 1.44
Proteomic analysis of cervical-vaginal fluid: identification of novel biomarkers for detection of intra-amniotic infection. J Proteome Res (2007) 1.23
Proteomic analysis of human cervico-vaginal fluid. J Proteome Res (2007) 1.23
CAF-mediated human immunodeficiency virus (HIV) type 1 transcriptional inhibition is distinct from alpha-defensin-1 HIV inhibition. J Virol (2003) 1.17
Vaginal douching: association with lower genital tract infections in African pregnant women. Sex Transm Dis (1999) 1.16
Glycodelin: a major lipocalin protein of the reproductive axis with diverse actions in cell recognition and differentiation. Endocr Rev (2002) 1.13
Proteomic analysis of human plasma: failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins. Proteomics (2001) 1.09
Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr (2001) 1.04
Proteomic analysis of human cervical-vaginal fluids. J Proteome Res (2007) 1.04
Globular structure of human ovulatory cervical mucus. FASEB J (2007) 1.00
Shotgun proteomic analysis of vaginal fluid from women in late pregnancy. Reprod Sci (2008) 0.94
Proteomic analysis and characterisation of human cervico-vaginal fluid proteins. Aust N Z J Obstet Gynaecol (2007) 0.93
High performance ion exclusion chromatographic characterization of the vaginal organic acids in women with bacterial vaginosis. Biomed Chromatogr (1993) 0.89
Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo. J Clin Endocrinol Metab (2000) 0.89
Comparative study of [Three] LC-MALDI workflows for the analysis of complex proteomic samples. J Proteome Res (2005) 0.86
The pathophysiology of rhinitis. III. The control of IgG secretion. J Allergy Clin Immunol (1989) 0.84
Morphometric characteristics of the vaginal epithelium during the menstrual cycle. Gynecol Obstet Invest (1988) 0.81
Infection with Human Papillomavirus alters expression of the small proline rich proteins 2 and 3. J Med Virol (2004) 0.80
Human papillomavirus type 11 alters the transcription and expression of loricrin, the major cell envelope protein. Virology (2002) 0.80
Role of human papilloma virus testing in cervical cancer prevention. J Midwifery Womens Health (2004) 0.80
Reproducibility of LC-MS-based protein identification. J Exp Bot (2006) 0.79
The effects of carbonic anhydrase inhibitors on aqueous humor chemistry and dynamics. Invest Ophthalmol Vis Sci (1984) 0.76
Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials. Lancet Oncol (2015) 4.84
Use of the levonorgestrel-releasing intrauterine system in breast cancer patients. Fertil Steril (2007) 1.48
Primary small cell neuroendocrine tumour of the breast. Eur J Obstet Gynecol Reprod Biol (2004) 1.10
The value of AFP in congenital cervical teratoma. J Pediatr Surg (2003) 1.02
Cervical adenocarcinoma: moving towards better prevention. Vaccine (2011) 0.93
Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women. Int J Cancer (2004) 0.89
Microarray-based oncogenic pathway profiling in advanced serous papillary ovarian carcinoma. PLoS One (2011) 0.84
Don't forget HPV-45 in cervical cancer screening. Am J Clin Pathol (2012) 0.82
Intimate examination teaching with volunteers: implementation and assessment at the University of Antwerp. Patient Educ Couns (2006) 0.81
The rapid development of a giant condyloma acuminatum (Buschke-Löwenstein tumor) during pregnancy. Acta Obstet Gynecol Scand (2007) 0.80
Horner's syndrome: an ominous sign in breast cancer. Eur J Obstet Gynecol Reprod Biol (2006) 0.79
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ. Lancet (2003) 0.79
Anal human papillomavirus DNA in women at a colposcopy clinic. Eur J Obstet Gynecol Reprod Biol (2012) 0.78
Suspicious nipple discharge and breast magnetic resonance imaging. Breast J (2004) 0.78
The thoughts of breast cancer survivors regarding the need for starting hormone replacement therapy. Eur J Obstet Gynecol Reprod Biol (2005) 0.77
Three pathognomonic signs of a laparoscopic complication. Acta Obstet Gynecol Scand (2005) 0.77
Comparative proteomics of copper exposure and toxicity in rainbow trout, common carp and gibel carp. Comp Biochem Physiol Part D Genomics Proteomics (2012) 0.76
The rationale for mTOR inhibition in epithelial ovarian cancer. Expert Opin Investig Drugs (2009) 0.76
Tjalma's syndrome. Lancet (2006) 0.76
Plasma concentrations of levonorgestrel in patients with an intrauterine progestogen delivery system: do they have any significance? Maturitas (2006) 0.76
Treatment of Aggressive Pelvic Fibromatosis With Interferon. Obstet Gynecol (2015) 0.76
Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol (2006) 0.75
Extramammary Paget's disease of the vulva. J Am Coll Surg (2003) 0.75
Ovarian conservation and hormone receptors in uterine Müllerian adenosarcomas. Gynecol Oncol (2003) 0.75
Combined Pap and HPV testing in primary screening for cervical abnormalities: should HPV detection be delayed until age 35? Eur J Cancer (2005) 0.75
False-positive positron emission tomographic scan and computed tomography for recurrent vaginal cancer: pitfalls of modern imaging techniques. Gynecol Oncol (2004) 0.75
The thoughts of physicians regarding the need to start hormone replacement therapy in breast cancer survivors. Eur J Obstet Gynecol Reprod Biol (2005) 0.75
Pitfall of the missing swab. Gynecol Oncol (2004) 0.75
Abandon the intrauterine catheter and delay the cerclage in a radical trachelectomy. Gynecol Oncol (2007) 0.75
The missing ink. Eur J Obstet Gynecol Reprod Biol (2007) 0.75
HPV 18 antibody levels, clinical efficacy and induced immune memory: a trio? Vaccine (2009) 0.75